Special Feature
Pharm Exec's 11th Annual Industry Audit
It's time again for our annual industry audit, which aims to provide a snapshot of how well companies are doing in advancing shareholder value. That now depends on finding pockets of "good" growth, in segments with fewer players, and where expenses can be tightly controlled
...Read more
Advertisement
Statistical methodologies will help you capture and use drug experience data to generate meaningful inferences from pooled and observational data. This paper focuses on one such premier methodology, meta-analysis. We illustrate the application of the traditional methods of meta-analysis and also the more recent Bayesian approach to meta-analysis in the context of RAA (renin-angiotensin-aldosterone) system blockers/antagonists.
 www.Sciformix.com/smartstudy.php |
Technology
In the Rush Toward Customer Engagement, Can Technology Help Find That Sweet Spot?
The central question of Cegedim Relationship Management's annual conference on trends in the life sciences industry last week was 'If the business of pharma is changing at warp speed, then what new strategies and practices are best poised to help companies maintain a competitive advantage?'
...Read More
Emerging Markets: Biologics
The Big Sell
High-priced biologics may have a bright future in emerging markets, but winning access in the short term will be a hard sell, writes Thomas Baker ...Read More
Emerging Markets: Healthcare
Russian Women Bearing the Brunt of Out-of-Pocket Medication Costs
Russia's mandatory health insurance (MHI) system theoretically provides free, universal healthcare throughout the country; the reality, however, is somewhat different, according to research from Kantar Health
...Read more |
